CRESS | $234,000 | (Feb 21, 2025)
Safe Intelligence | $5,253,443 | (Feb 21, 2025)
Reverb Therapeutics | $21,000,000 | (Feb 21, 2025)
Terrain Biosciences
United States
- Cambridge, Massachusetts
- 20/02/2025
- Seed
- $9,000,000
At Terrain Bio, we help RNA therapeutics companies design and build better RNA, faster. Leveraging the latest innovations in protein and RNA design and the deep expertise of its scientific cofounders, we bring unparalleled speed and quality to RNA manufacturing.
- Industry Biotechnology Research
- Website https://www.terrainbiosciences.com/
- LinkedIn https://www.linkedin.com/company/terrain-biosciences/
Related People
Chetan TadvalkarFounder
United States -
Greater Boston
Founding CEO at Terrain Bio - we're making better RNA possible and supporting the next wave of therapeutic innovation!
I've spent my career working in and building businesses that enable pharma and biotech companies to innovate, including PE-backed category leaders like DRG and Biorasi as well as public companies like Ginkgo Bioworks. I started my career at BCG where I worked on 20+ projects across life sciences and the PE space.
I received an undergraduate degree from Yale University, and an MBA from the Wharton School, graduating as a Palmer Scholar (top 5% of class).
QuSecure | $28,000,000 | (Feb 21, 2025)
AheadComputing | $21,500,000 | (Feb 21, 2025)
Together AI | $30,000,000 | (Feb 21, 2025)
Kodesage | $2,300,000 | (Feb 21, 2025)
OpenEvidence | Undisclosed Amount | (Feb 21, 2025)
Oso Semiconductor | $5,200,000 | (Feb 21, 2025)
EnPlusOne Biosciences | $10,000,000 | (Feb 21, 2025)
Pinkfish | $7,600,000 | (Feb 21, 2025)
Esperto Medical | Undisclosed Amount | (Feb 21, 2025)